The 2nd seminar of the Korea Future Medical Innovation Research Association (hereinafter referred to as Hanmiyeon), which was launched last March, was successfully held on the 19th at the Andaz Hotel in Gangnam.
Hanmiyeon is a research association formed by experts from various fields of the medical field, positioning itself as a think tank that researches and proposes future medical innovation policies to enhance Korea's medical competitiveness and future value.
Previously, at the first seminar held in April, Hanmiyeon covered the overall healthcare system of Healthcare 4.0 and presented policy proposals related to the training of physician-scientists. The 2nd seminar held this time conducted in-depth discussions related to digital healthcare.
At the seminar, attendees included Kang Daehee, president of the Telemedicine Society and co-representative of Hanmiyeon; Lim Jong-yoon, president of Hanmi Pharmaceutical; as well as newly joined operating committee members such as Noh Hong-in, full-time vice president of the Korea Hospital Association; Ko Kyung-mo, CEO of Eugene Investment & Securities; Yoo Seok-hwan, CEO of Rokit Healthcare; Yoo Kyung-ho, director of Hallym University Sacred Heart Hospital; Park Hee-kyung, CEO of Siseon Bio; and Cho Min-sik, vice chairman of Bestpin Global.
Also present to brighten the occasion were Hanmiyeon advisors including Ahn Cheol-soo, member of the People Power Party, and Ahn Do-gul, member of the Democratic Party; operating committee members Park Soo-min, Choi Su-jin, and Han Ji-a of the People Power Party; and Kim Yoon of the Democratic Party.
Co-representative Lim Jong-yoon emphasized medical reform for the advancement of Healthcare 4.0 in his opening remarks. Healthcare 4.0 is a concept emphasizing universal health coverage for all citizens, centering on the patient with a system focused on ‘Connected Healthcare.’ Lim stated, “Following the government-led innovation in medical services through digital healthcare technologies such as data and AI after COVID-19, Hanmiyeon plans to present high-quality future medical reform policies.”
In his congratulatory remarks, Assemblyman Ahn Cheol-soo said, “Having experienced medical volunteer work in Daegu during COVID-19, I deeply felt the importance of a robust public healthcare system in a national crisis,” and added, “I look forward to Hanmiyeon’s significant role in enabling Korea’s medical system to achieve innovation and build a solid foundation.”
Assemblymen Park Soo-min, Choi Su-jin, Han Ji-a of the People Power Party, and Ahn Do-gul and Kim Yoon of the Democratic Party also stressed the necessity of future medical reform and emphasized the importance of policy promotion and the paradigm shift to digital healthcare.
Chairman Noh Yeon-hong of the Special Committee on Medical Reform, which has recently attracted great attention, also added meaning to the Hanmiyeon seminar by stating in his greeting, “We will listen closely to Hanmiyeon’s policy proposals in building Korea’s future medical system.”
In the first session of the seminar, Hwang Hee, CEO of Kakao Healthcare, delivered a presentation titled ‘Connected Healthcare, Patient Participation, and Digital Healthcare for Data Science,’ explaining the importance of patient-centered connected healthcare in the digital healthcare field from the perspective of data science. In the second session, Lee Young-shin, CEO of Sears Technology, presented on ‘Successful Digital Healthcare Startup IPO Cases.’ Lee shared the company’s integrated capabilities and IPO success know-how, citing Sears Technology’s experience in bio-materials, medical device manufacturing, AI, and software technologies.
During the subsequent open discussion, opinions were exchanged on the importance of AI clinical support systems that assist in prescribing treatments and preventive medications for various diseases. It was agreed to establish an initial clinical support system based on patient-specific prescriptions and outcomes, and to apply this system in clinical practice to create an environment where clinicians can derive optimal personalized prescriptions for each patient.
In the closing remarks, co-representative Kang Daehee stated, “The biggest topic in the medical community recently is personalized treatment, and integration with AI can be seen as a trend of the times,” adding, “Hanmiyeon’s role is essential and meaningful in laying the foundation for future industries at a national level to ensure such systems take root.”
Hanmiyeon is known to be moving swiftly to realize the digital health support measures and physician-scientist training plans derived from the first seminar.
Hanmiyeon operating committee chairman Han Sung-joon, CEO of Evixgen and CTO of Coree&Dx&Vx, said, “Hanmiyeon operates a ‘Hanmiyeon Research Committee’ separately from regular seminars and plans to refine concrete implementation plans for the proposals derived.”
Meanwhile, at the 3rd seminar scheduled for August, Min Jeong-jun, director of Hwasun Jeonnam National University Hospital, and Yoo Kyung-ho, director of Hallym University Sacred Heart Hospital, are expected to present on the topic of ‘Development of Regional Healthcare.’ Among the five seminars planned for this year, the final seminar scheduled for December will be held in an open format to allow participation from the general public and foster lively discussions.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
